From tobacco to medicine… Philip Morris, which manufactures Marlboro cigarettes in particular, will acquire the Danish pharmaceutical company Fertin Pharma for 820 million dollars. This company, which belonged to the EQT fund and generated $ 160 million in sales last year, has specialized in tobacco substitutes (chewing gum, gums, powders, tablets, etc.). “
The acquisition of Fertin Pharma is a major step in our ambition to create a smoke-free world,”
said Jacek Olczak, who took over the reins of Philip Morris International (PMI) last May.
It allows us to expand our portfolio of smoke-free products and accelerate our progress beyond nicotine.
"
Read also:
Cigarettes soon to be a minority in Marlboro sales
By getting its hands on this laboratory, which has factories in Denmark, Canada and India, PMI intends to develop pharmaceutical or wellness products in areas such as sleep, energy, calm or relaxation. concentration.
The know-how
This article is for subscribers only.
You have 75% left to discover.
To cultivate your freedom is to cultivate your curiosity.
Continue reading your article for € 1 the first month
I ENJOY IT
Already subscribed?
Log in
/cloudfront-eu-central-1.images.arcpublishing.com/prisa/AW2KNQ2UOZA4PHPLO4DEKRFIOQ.jpg)
